June 6 2019 - Barcelona

The second edition of the EBART congress organised by the Eugin Group was attended by more than 400 healthcare professionals from 24 countries. The congress, among other subjects, dealt with the importance of how the Assisted Reproduction Technology professionals have to educate themselves towards an evidence-based approach to medicine without hang-ups and without any kind of fear. Also, about the fact that we have to be more and more aware that education at an early stage of life is the keystone in the fight against fertility.

Welcome letter

Dear friends and colleagues,

Assisted reproduction is a branch of medicine undergoing very rapid changes. We are frequently faced with the responsibility of deciding whether a particular technique is beneficial to our patients.

Where should we find the information? Evidence-based medicine offers the answer to this question, as we strive to offer the highest standard of care to our patients.

We are delighted to welcome you to Barcelona for the second EBART (evidence-based assisted reproductive technology) conference in April 2018.

Together, we will discuss about clinical IVF, implantation, cycle optimization, genetics, male factor and ethics and society… And a great deal more by applying an evidence-based approach, evaluating current research data and level of evidence!

We encourage you to join us for 2 days of medicine and science, and look forward to seeing you all in a few months.


  • Amelia Rodríguez-Aranda

    Amelia Rodríguez-Aranda


  • Rita Vassena

    Rita Vassena



The EBART 2nd Congress Evidence based assisted Reproduction Technology, Barcelona, Spain, 05/04/2018-06/04/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.


  • Georg Griesinger

    Georg Griesinger


  • Nick Macklon

    Nick Macklon


  • Siladitya Bhattacharya

    Siladitya Bhattacharya


  • Claudia Spits

    Claudia Spits



  • Day 1

    5 April 2018

    • 08:00 - 08:30


    • 08:15 - 08:30

      Opening address

      Amelia Rodríguez-Aranda (Spain) / Rita Vassena (Spain)

    • 08:30 - 09:00

      Keynote lecture: Genetic instability in embryonic development

      Dietrich Egli (USA)

    • 09:00 - 11.00

      Clinical IVF: Techniques and result


      Georg Griesinger (Germany) / Amelia Rodríguez-Aranda (Spain)

      Too much treating not enough preventing

      Rita Vassena (Spain)

      ICSI: current use based on evidence or abuse? Re-evaluate the trend

      Siladitya Bhattacharya (UK)

      What chance of success in ART is reasonable? When should we stop treatment? Patient autonomy versus evidence based

      Georg Griesinger (Germany)

      Perinatal outcomes in third party reproduction

      Anna Blázquez (Spain)

    • 11:00 - 11:30

      Coffee break

    • 11:30 -13:30



      Anja Pinborg (Denmark) / Aïda Pujol (Spain)

      Managing implantation: when desperation clouds reason

      Nick Macklon (Denmark)

      Endometrial NK cells, senescence and implantation

      Paul John Brighton (UK)

      Single embryo transfer. Expectations and reality

      Christina Bergh (Sweden)

    • 13:30 - 15:30

      Lunch break

    • 15:30 - 17:00

      Cycle optimization


      Giovanni Coticchio (Italy) / Karinna Lattes (Spain)

      Blastocyst culture vs. cleavage stage: what system gives higher CPR?

      Aisling Ahlström (Sweden)

      Vitrification as a tool for cycle optimization

      Amelia Rodríguez-Aranda (Spain)

      Freeze-all: better PR or just a matter of safety? A critical appraisal

      Samuel Dos Santos Ribeiro (Belgium)

    • 17:00


  • Day 2

    6 April 2018

    • 08:00 - 10:00



      Nick Macklon (Denmark) / Rita Vassena (Spain)

      The link between the mitochondrial genome and ART

      Claudia Spits (Belgium)

      What should we do with mosaic embryos

      Nathan Treff (USA)

      Evidence based PGS: an update

      Georg Griesinger (Germany)

    • 10:00 - 10:30

      Selected oral communication


      Maria Beatrice Dal Canto (Italy) / Eduardo Motta (Brasil)

      3 communications chosen among the submitted abstracts

    • 10:30 - 11:00

      ART in the world: Present data and future perspectives

      Jacques de Mouzon (France)

    • 11:00 - 11:30

      Coffee break

    • 11:30 - 13:30

      Male factor


      Ursula Eichenlaub-Ritter (Germany) / Ignacio Madero (Colombia)

      Proteomic analysis of male factor

      Charles Pineau (France)

      IVF vs. IUI: what should we chose and when

      Anja Pinborg (Denmark)

      Should we care about sperm DNA damage and how?

      Madelon Van Wely (The Netherlands)

    • 13:30 - 15:30

      Lunch break

    • 15:30 - 17:30

      Ethics and society


      Svend Lindenberg (Denmark) / Mauricio Chehin (Brasil)

      Oncofertility: is universal access advisable?

      Richard Anderson (UK)

      Expanded carrier screening: ethical challenges.

      Pascal Borry (Belgium)

      Disclosure of donor conception and the right to know about one’s genetic origin

      Guido Pennings (Belgium)

      Surrogacy in Europe: to allow, to regulate, to forbid?

      Françoise Shenfield (UK)

    • 17:30



AXA Auditorium and Convention Center

Avinguda Diagonal, 547, 08029 Barcelona


What makes the EBART Congress different from other ART conferences?
Our directors and medical professionals provide you with some of the reasons why... Don't miss this opportunity!


  • EBART is around the corner.

    See you there to share experiences and discuss about clinical IVF, implantation, cycle optimization, genetics, male factor and ethics and society… And a great deal more by applying an evidence-based approach, evaluating current research data and level of evidence! We are ready to give you a warm welcome in Barcelona.

  • Download the EBART Congress app

    The EBART app is out! You have all the information in the palm of your hand. Check out the program, the speakers and all the information about the Congress. But above all, you’ll be able to share your comments and votes in the “Voting” section. All the questions will be available at the beginning of…

  • EBART is special and different because…

    We asked some professionals in the field “What sets EBART apart from other conferences?” and they answered: Ignacio Madero, from Colombia. Mario Brassesco, from Spain. What about you? I want to be part of it!

Download the EBART Congress app